| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.429 | 33.649 | 36.261 | 0 | 55.756 | 67.122 | 56.563 | 47.100 | 60.933 | - |
| Total Income - EUR | 28.429 | 33.649 | 36.261 | 0 | 55.756 | 67.122 | 56.563 | 47.100 | 60.933 | - |
| Total Expenses - EUR | 14.307 | 16.096 | 16.330 | 0 | 28.018 | 18.114 | 15.334 | 17.751 | 17.390 | - |
| Gross Profit/Loss - EUR | 14.122 | 17.553 | 19.931 | 0 | 27.738 | 49.008 | 41.229 | 29.349 | 43.542 | - |
| Net Profit/Loss - EUR | 13.270 | 16.877 | 19.568 | 0 | 27.180 | 48.369 | 40.729 | 29.051 | 42.933 | - |
| Employees | 1 | 2 | 2 | 0 | 2 | 2 | 3 | 2 | 2 | - |
Check the financial reports for the company - Mirey & Adrya Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 440 | 1.078 | 542 | 31 | 0 | - |
| Current Assets | 22.973 | 39.738 | 58.666 | 0 | 100.774 | 133.787 | 103.503 | 87.948 | 102.719 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 270 | 739 | 687 | 0 | 1.028 | 35.394 | 79.337 | 37.501 | 74.590 | - |
| Cash | 22.703 | 38.998 | 57.979 | 0 | 99.746 | 98.393 | 24.167 | 50.447 | 28.129 | - |
| Shareholders Funds | 22.368 | 39.016 | 57.924 | 0 | 33.595 | 81.390 | 74.122 | 84.792 | 98.505 | - |
| Social Capital | 45 | 45 | 44 | 0 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 605 | 721 | 742 | 0 | 67.619 | 53.475 | 29.923 | 3.187 | 4.214 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mirey & Adrya Medical Srl